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Abstract
Background: Mycetoma is a chronic granulomatous infectious disease caused by filamentous bacteria or by fungi.
The disease is endemic in certain tropical and subtropical areas of the world but can be found elsewhere posing
sometimes a diagnostic challenge for clinicians.
Case presentation: A 65-year- old man presented with a right foot swelling evolving for 25 years. During that
time, several diagnosis and treatments have been made without any improvement. The disease spread to bones,
and misdiagnosed as Kaposi’s sarcoma. Transtibial amputation has been performed, and the histopathological
examination revealed finally the diagnosis of eumycotic mycetoma. The patient recovered well after surgery and
orthopedic prosthesis was prescribed for him.
Conclusion: Mycetoma in non endemic areas is usually misdiagnosed and mismanaged leading to unnecessary and
inappropriate surgery. Health practitioners should be aware of that fact in order to provide an accurate management.
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Background
Madura foot or mycetoma is a chronic granulomatous
disease of the subcutaneous tissue, that can progress to
deeper structures like muscles or bones [1–3]. It is
caused either by fungi (eumycetoma) or by aerobic fila-
mentous bacteria (actinomycetoma) [1, 4]. It affects
mostly lower extremities of the body, especially foot
and leg but can affect any part of the body, such us
head and neck, arms, the chest wall or the abdominal
wall [1, 2, 5]. The disease often occurs in tropical and
subtropical regions of the world, in the zone called
“mycetoma belt”, extending between latitudes 15° south
and 30° north [1, 3, 6]. Mexico, Senegal, India, Sudan,
are the most affected countries [1–4]. Sudan seems to
be the most endemic country where eumycetoma rep-
resents the main aetiologic type of the disease. This
country hosts an important research center for myce-
toma where large studies on the topic were performed
[5]. But, in temperate climate, cases of mycetoma have
been reported, mostly imported cases from immigrants
[7–10]. In 2014, Buonfrate et al. had reported 42 cases
of mycetoma acquired in Europe, through a literature
review, suggesting that Europeans without travel his-
tory can be affected by the disease [11]. Typically, my-
cetoma is encountered in rural areas in poor people
working in agricultural sector [1, 3, 5]. In 2013, the
World Health Organisation (WHO) listed the disease
among neglected tropical disease [12]. Several causative
fungal or bacterial agents are responsible for the
disease. The treatment is based on the type of causative
agent, bacterial or fungal, and on the extent of the dis-
ease. Unfortunately, the diagnosis of the disease and
the identification of the etiological agent is a very chal-
lenging issue, especially in non-endemic areas [13–16].
We report herein, a case of Madura foot evolving for
more than 2 decades, that had escaped all diagnostic
tools, misdiagnosed as cancer and leading finally to am-
putation. The final diagnosis has been achieved by the
histopathological examination of the resected specimen.
Case presentation
A 65-year-old man was referred for evaluation of the
right foot tumor diagnosed recently as Kaposi’s sarcoma.
The patient was a shopkeeper living in the town of Fès
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and did not report any trip to an endemic area of myce-
toma. He had a right foot chronic lesion for 25 years,
with several repeated histological biopsies revealing, ke-
loid scar, non specific inflammation, or Kaposi’s Sar-
coma. The Physical examination showed chronic skin
changes on the right foot and leg, with multiple scars
and hard abscessed ulcerations on the plantar face of
the foot. There were no grain discharge and the patient
did not report such information. The culture of the
abscess showed Staphylococcus aureus species. X-ray of
the right foot was performed and showed extensive de-
struction of the tarse, metatarse and phalanges (Fig. 1).
Other radiological evaluation did not found further
lesions. The diagnosis of locally invasive Kaposi’s
Sarcoma was suspected and a right trans-tibial amputa-
tion was performed.
Histopathological findings
On macroscopic evaluation, the leg measured 30x11cm,
the foot measured 27x10cm. The foot showed an indu-
rated skin with some areas of hard abscess without any
disharges. The initial sampling from these lesions
showed a non specific inflammation without any tu-
moral lesion. Then, the remaining bone was submitted
to decalcification by nitric acid. Some weeks later, after
the process of decalcification, the macroscopic evalu-
ation found a deep soft tissue and bone destruction
consisted of round cavitis filled of yellowish crumbly
material (Fig. 2). The histological examination on
hematoxylin-eosine-safran (HES) stained sections re-
vealed several multilobulated colonies surrounded by
granulomatous inflammation composed of plasma cells,
epithelioid cells, macrophages and some multinucleated
cells. The colonies had deeply basophilic outer layers
with branching filaments (Figs. 3 and 4); some colonies
were fractured and had a pale center. They stained posi-
tive for PAS (Periodic Acid-Schiff ) (Fig. 5). These histo-
logical aspects were strongly consistent with eumycotic
mycetoma. The post-operative course was uneventful
and the patient was discharged from the hospital. Two
months after surgery, the patients had no signs of the
disease and orthopedic prosthesis was prescribed for
him.
Discussion
Mycetoma is one of the neglected infectious diseases
that is endemic in tropical and subtropical areas of the
world [1, 5, 6]. The disease affects typically poor people
living in rural areas and usually working in farms. Myce-
toma affects all age groups, but it is more common in 20
– 40 year old men; this epidemiological feature suggests
that young men are more exposed to the disease because
they are supposed to be the more productive age group
in developping countries [1, 3, 4]. The low prevalence of
the disease in women could be due to hormonal factors
as in rural areas women take part in agricultural and
other activities that expose to mycetoma [1]. But, in
countries out of the ‘’mycetoma belt”, in temperate cli-
mate regions, cases of mycetoma have been reported
from immigrants [7–10]. Also, cases from autochtonous
patients without history of travelling to endemic regions,
have been reported [11]. Health practitionners in these
areas are not familiar to the disease, thus cases were
usually misdiagnosed and mismanaged leading to serious
consequences for patients. In fact, our case, is from
Morocco, a country that is out of the ‘’mycetoma belt”,
where no more than 100 cases have been reported.
Several causative micro-organisms (more than 56), ei-
ther fungi or bacteria, are known to date to be linked to
mycetoma [1, 4, 6]. They are found in the environnment
in plants thorns or in the soil. People become infected
Fig. 1 X rays of the foot showing extensive osteomyelitis with tarsal,
metatarsal and phalange bones destruction (arrows)
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by the disease after injury by plants thorns or when
walking bearfoot [4, 6]. The prevalence of causative
agents vary in the world. In Sudan, the main causative
agents are fungi, while in latin America, in countries like
Mexico, bacterial agents are predominant. One recent
review and meta-analysis, found that the species like
Actinomadura madurae, Streptomyces somaliensis, Acti-
nomadura pelletieri, Nocardia brasiliensis and Nocardia
asteroides were considered to be common causative
agents of actinomycetoma, while Madurella mycetomatis
was the main causative agent of eumycetoma [1].
The clinical presentation of mycetoma is similar
whether the causative agent is a fungi or a bacteria,
however actinomycetoma has more agressive course and
invades deeper structures earlier than eumycetoma [1].
Typically, patients present with a classical triad consisted
of a painless firm subcutaneous mass, multiple sinus for-
mation, and a purulent or seropurulent discharge con-
taining grains. The disease pursues a long course,
because of the indolor feature or the lack of appropriate
health information about the disease, hence it occurs in
poorly educated patients. Another factor that explains
the long evolution of the disease, is the misdiagnosis es-
pecially in non endemic regions, as illustrated by our
case that has disease for more than 20 years, repeatdly
misdiagnosed, leading to leg amputation. Similarly,
Fig. 2 The resected specimen showing cavitis filled of yellowish materiel (arrow) corresponding to mycetoma grains
Fig. 3 Histological aspects (HES stained section) with a fractured
colony destroying the bone tissue
Fig. 4 The histological image (HES stained section) showing a
mycetoma colony with deeply basophilic outer layer and a
pale center
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mycetoma cases have been reported in Europe, with long
course and subsequent amputation [11].
The more challenging issue with mycetoma is the
diagnosis in early stage of the disease before complica-
tions that could lead to aggressive therapeutic option
such as amputation. The issue becomes even more chal-
lenging when it comes to identification of the causative
agent. In fact, the treatment depends on the type of the
causative microorganism and on the severity and exten-
sion of the disease. The imaging technics such as X-rays,
ultrasonography, computed tomography (CT Scan) and
magnetic resonance imaging (MRI) allow easily to assess
the extension of mycetoma especially invasion of deeper
structures like muscles or bones [13, 14, 16].
To identify the causative agents, culture methods are
considered the gold standard as they allow the identifica-
tion of the wide species linked to mycetoma [1, 13, 16].
However cultures methods are time consuming, certain
species are difficult to identify, and contaminations are
common. [1, 13, 14] The culture failed to identify the
causative agent in our case, it only has identified stapy-
loccocus aureus species. Similarly, skin tests or serology
could be used to identify the causative agents at species
level, but these technics are not fully reliable [1, 13, 16].
Currently, molecular technics are the only reliable diag-
nostic tool to identify the exact species of the causative
organisms. The main drawback of molecular technics is
their high cost for developing countries where myce-
toma is mostly endemic [1, 13]. Histopathology is
another diagnostic tool that can aid to identify the
causative agent. The main merits of pathology is to dif-
ferentiate eumycetoma from actinomycetoma, identifica-
tion at species level is not reliable, almost impossible
[13–17]. Grains of the causative agent can be obtained
by cotton swab from sinuses, by fine needle aspiration
or by biopsy [1, 6, 16, 17]. Superficial grains from sinuses
are often non viable and contaminated with other organ-
isms, ideally deep-seated grains provide more diagnostic
informations. The macroscopic examination of grains do
not provide any specific diagnostic orientation. Eumyce-
toma could have black, white or yellow grains, whereas
actinomycotic grains could have yellow, white, red or
pink color. However, in a long standing disease, fibrotic
lesions can be so extensive that discharge from sinuses
becomes scarce or completely inapparent [14]. Biopsy
from these lesions are always non conclusive or mislead-
ing, showing non specific inflammation or mimic certain
malignancies, as commonly reported in the literature. In
fact, the important population of reactive fibroblasts and
histiocyts, along with fibrotic and haemorrhagic changes,
may lead some pathologists to think about Kaposi sar-
coma. The long course of the disease and its extension
to adjacent structures may also play a role in the mis-
diagnosis of malignancies. Recently, in Morocco, another
case has been reported where the patient had been mis-
diagnosed as Kaposi’s sarcoma, and given chemotherapy
before the correct diagnosis of mycetoma [18]. Typically,
our case illustrated also the diagnostic challenge posed
by mycetoma especially in non endemic areas. The
patient had several biopsies that showed non specific
inflammation, the latest has concluded to Kaposi’s sar-
coma invading bone structures, justifying amputation.
The histopathological diagnostic approch uses hematein-
eosin-safran (HES) stain combined with other special
stain such as PAS, Gram stain, Ziehl Nielson stain (ZN),
Grocott satin,…etc. [1, 13–17]. With HES stain, the
grains represent colonies of the causative agent, sur-
rounded by granulomatous inflammation composed of
plasma cells, polymorphonuclear cells, macrophages and
giant cells. Colonies from actinomycetoma have different
size, often round or multilobulated, with deeply stained
basophilic outer border and slightly paler center [14, 15,
18]. Sometimes, an eosinophilic hyaline-like material
surrounds the colonies, this aspect is referred to as
Splendore-Hoeppli Phenomenon [14]. The colonies may
also show fractured aspect [1, 14, 15]. The filaments are
thin, their thickness is no more than 1 μm [13–17]. Typ-
ically, actinomycotic colonies are Gram positive and
negative for PAS stain [13, 14]. Nocardia species stain
positively to ZN [1, 14]. Histologically, our case stained
postive to PAS, the fact that allowed us to rule out acti-
nomycetoma although colonies were multilobulated,
fractured and had basophilic outer layers with pale cen-
ters, at HES stain. Colonies from eumycetoma show
several histological aspects that can have overlapping
appearence with actinomycetoma colonies, but their fil-
aments are thicker, 2-6 μm [13, 14]. They stain positive
for PAS, negative for Gram stain or ZN stain. In fact, as
cultures are time-consuming, and sometimes negative,
pathology provides useful aid to discriminate between
Fig. 5 Histological image (PAS stained section) showing a positive
staining colony
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actinomycotic and eumycotic causative agents, by using
HES stain combined with other special stains [13–17].
Pathology also rule out any malignancy or specific
granulomatous inflammations such us tuberculosis.
Thus, treatment can be adjusted.
The treatment of mycetoma depends on the causative
agent, either fungal or bacterial, hence the necessary de-
termination of the type of causative organism. Both
eumycetoma and actinomycetoma are treated with anti-
fungal or antibacterial drugs, sometimes combined with
surgery. The treatment of eumycetoma uses antifungal
drugs belonging to the azole class, such as ketoconazole,
itranonazole, terbinafine or voriconazole. But since 2013,
there was some restrictions of the use of ketoconazole
by the US Food and Drug Administration, followed lat-
ter by the European Medicines Agency, because of sev-
eral side effects [1]. These drugs are used for months,
and associated with surgical debridement. Recurrences
are frequent, and compliance to treatment seems diffi-
cult [1, 4]. Actinomycetoma is treated by a combination
of trimethoprim and sulfamethoxazole with aminosids
(amikacin or netilmicine), for weeks. The prognosis of
actinomycetoma seems to be better compared to eumy-
cetoma [1, 6, 18]. Table 1 summarizes some different
charactristics of eumycetoma and actinomycetoma.
Despite the long-term treatment and recurrences ob-
served in medical treatment, aggressive surgery is not the
first line of treatment [1, 6, 19]. Amputations are generally
due to misdiagnosis or a long-standing disease that spreads
to deeper structures of the body [5, 7, 11, 18]. In fact, our
patient should have been treated medically, rather than sur-
gically, but the misdiagnosis due to the fact that clinicians
were not familiar to mycetoma here in Morocco, as it is not
an endemic area of mycetoma. Misdiagnosis and misman-
agement are common in non endemic regions.
Conclusion
We have reported a case of mycetoma in a non endemic
area, that evolved for more than 2 decades, misdiag-
nosed as a cancer and leading to an unnecessary and
aggressive surgery. This case illustrated well the diagnos-
tic challenge of mycetoma in certain areas of the world
where the disease is not endemic; health practitioners
should be aware of that in order to provide early diagno-
sis and appropriate treatment.
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